JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Taylor Morrison Home (TMHC) PT Lowered to $28 at JMP Securities
-
UPDATE: JMP Securities Upgrades Consumer Portfolio Services (CPSS) to Market Outperform
-
Tier Technologies (TIER) PT Raised to $25 at JMP Securities
-
Docusign Inc. (DOCU) PT Raised to $63 at JMP Securities
-
Medical Properties Trust (MPW) PT Raised to $15 at JMP Securities
-
Insmed to Present at Three June Conferences
-
Deciphera Pharmaceuticals (DCPH) Prices 4.3 Million Common Shares at $40/Share
-
Madrigal Pharma (MDGL) Announces 1.347 Million Shares of Common Stock Offering Price at $305/Share
-
JMP Securities Starts ShotSpotter (SSTI) at Market Outperform
-
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
-
Madrigal Pharmaceuticals Prices Public Offering of Common Stock
-
Deciphera Pharmaceuticals Announces Pricing of Public Offering
-
Cowen Announces Pricing of $90 Million Senior Notes Offering
-
Atlas Financial to Participate in JMP Securities Financial Services and Real Estate Conference on June 19, 2018
-
Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference
-
AxoGen, Inc. to Present at Upcoming Investor Conferences
-
AxoGen, Inc. to Present at Upcoming Investor Conferences
-
Protagonist Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference
-
JMP Securities Downgrades First Solar (FSLR) to Market Underperform
-
Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June
-
Wix.com (WIX) PT Raised to $100 at JMP Securities
-
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
-
Independent Research Firm Names Engagio a Strong Performer for Account Based Marketing (ABM) Platforms
-
DBV Technologies to Attend Upcoming Investor Conferences
-
DBV Technologies to Attend Upcoming Investor Conferences
-
Ultragenyx to Present at Upcoming Investor Conferences
-
Ultragenyx to Present at Upcoming Investor Conferences
-
EverQuote Files Registration Statement for Proposed Initial Public Offering of Class A Common Stock
-
JMP Securities Starts Evelo Biosciences Inc (EVLO) at Market Outperform
-
Palo Alto Networks (PANW) PT Raised to $240 at JMP Securities
-
Loxo Oncology (LOXO) PT Raised to $221 at JMP Securities; 'LOXO-292 Data at ASCO Exceeds Expectations'
-
Blueprint Medicines (BPMC) PT Lowered to $103 at JMP Securities
-
Ares Capital (ARCC) PT Raised to $18.50 at JMP Securities
-
Vanda Pharmaceuticals Announces Participation at June 2018 Investor Conferences
-
Domo, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Domo, Inc. Files Registration Statement for Proposed Initial Public Offering
-
Neos Therapeutics to Participate in Two June Conferences
-
Xencor to Present at Upcoming Investor Conferences
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $300 at JMP Securities
-
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Filing of Registration Statement for Proposed Initial Public Offering
-
Neuronetics Files $86M IPO; Plans to List Under Symbol 'STIM'
-
Bovie Medical Corporation to Participate in the JMP Securities 2018 Life Science Conference
-
Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights
-
Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights
-
Cherry Hill Mortgage Investment (CHMI) Prices 2.75M Share Offering for Expected Gross Proceeds of $49.6M
-
Cherry Hill Mortgage Investment Corporation Announces Pricing of Public Offering of Common Stock
-
Karyopharm to Participate in Upcoming Investor Conferences
-
Karyopharm to Participate in Upcoming Investor Conferences
-
Realm Therapeutics to Present at June Investor Conferences

